Replies to post #61353 on Ocata Therapeutics Inc fka OCAT

[lasers]

Yes based on $2000 to $3000 per RPE treated eye, $4000 to $6000 for both eyes, $ACTC would fund all of its planned clinical trials for the 2nd Generation RPEs to treated myopic and wet AMD as well as other stem cells for cornea regeneration and other eye diseases.